Literature DB >> 21316500

Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles.

M M Harmsen1, H P D Fijten, D F Westra, J M Coco-Martin.   

Abstract

Intact (146S) foot-and-mouth disease virions (FMDVs) can dissociate into specific (12S) viral capsid degradation products. Using two single-domain antibody fragments that bind specifically to either 146S or 12S particles we developed two ELISAs for the quantification of these particles in FMDV antigen preparations used for vaccine manufacturing. Only O serotype strains are detected in the 146S specific ELISA whereas strains of most serotypes are detected in the 12S specific ELISA. However, the 146S concentration of A and Asia 1 serotype strains could be measured indirectly using the 12S specific ELISA by prior conversion of 146S into 12S particles by heat treatment. This allowed us to demonstrate that addition of the preservative thiomersal to FMDV antigens stimulates the dissociation into 12S particles of O, A and Asia 1 serotype strains upon prolonged storage at 4°C. FMDV dissociation is known to result in a strongly reduced immunogenicity, which was experimentally confirmed here. Therefore, we recommend to omit thiomersal from FMD vaccines to increase its shelf life.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316500     DOI: 10.1016/j.vaccine.2011.01.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens.

Authors:  Ah-Young Kim; Sun Young Park; Sang Hyun Park; Jae Young Kim; Jong Sook Jin; Eun-Sol Kim; Jong-Hyeon Park; Young-Joon Ko
Journal:  Vaccines (Basel)       Date:  2022-04-22

2.  Structural and molecular basis for foot-and-mouth disease virus neutralization by two potent protective antibodies.

Authors:  Hu Dong; Pan Liu; Manyuan Bai; Kang Wang; Rui Feng; Dandan Zhu; Yao Sun; Suyu Mu; Haozhou Li; Michiel Harmsen; Shiqi Sun; Xiangxi Wang; Huichen Guo
Journal:  Protein Cell       Date:  2021-02-18       Impact factor: 15.328

3.  Unique stabilizing mechanism provided by biocompatible choline-based ionic liquids for inhibiting dissociation of inactivated foot-and-mouth disease virus particles.

Authors:  Xuan Lin; Yanli Yang; Shuai Li; Yanmin Song; Guanghui Ma; Zhiguo Su; Songping Zhang
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 3.361

4.  Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1).

Authors:  Lucy Gordon; Neil Mabbott; Joanna Wells; Liudmila Kulik; Nick Juleff; Bryan Charleston; Eva Perez-Martin
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 6.823

5.  Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design.

Authors:  Abhay Kotecha; Julian Seago; Katherine Scott; Alison Burman; Silvia Loureiro; Jingshan Ren; Claudine Porta; Helen M Ginn; Terry Jackson; Eva Perez-Martin; C Alistair Siebert; Guntram Paul; Juha T Huiskonen; Ian M Jones; Robert M Esnouf; Elizabeth E Fry; Francois F Maree; Bryan Charleston; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2015-09-21       Impact factor: 15.369

Review 6.  Factors contributing to the immunogenicity of meningococcal conjugate vaccines.

Authors:  Michael Bröker; Francesco Berti; Paolo Costantino
Journal:  Hum Vaccin Immunother       Date:  2016-03-02       Impact factor: 3.452

7.  Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.

Authors:  Michiel M Harmsen; Julian Seago; Eva Perez; Bryan Charleston; Phaedra L Eblé; Aldo Dekker
Journal:  Front Immunol       Date:  2017-08-17       Impact factor: 7.561

8.  Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate.

Authors:  Abhay Kotecha; Eva Perez-Martin; Yongjie Harvey; Fuquan Zhang; Serban L Ilca; Elizabeth E Fry; Ben Jackson; Francois Maree; Katherine Scott; Corey W Hecksel; Michiel M Harmsen; Valérie Mioulet; Britta Wood; Nick Juleff; David I Stuart; Bryan Charleston; Julian Seago
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.